Neostem Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lisata Therapeutics Inc (LSTA)
Track today's live Lisata Therapeutics (LSTA) share price, performance and key data on this page with our current NASDAQ:LSTA stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Lisata Therapeutics share price on the NASDAQ exchange. Use the dropdown to switch exchange for the LSTA share price, head to our technical summary section, which provides analysis on Lisata Therapeutics share price buy/sell indicators using real-time data (or discuss the Lisata Therapeutics (LSTA) stock price today with other investors in the Lisata Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:LSTA share price (ISIN: US1280583022) to enhance your trading decisions with our free investment tools and resources.
What Is the Lisata Therapeutics Inc Share Price Today?
The Lisata Therapeutics share price today is 1.0900.
What Is the Stock Symbol for Lisata Therapeutics Inc
The stock symbol (or 'ticker') for Lisata Therapeutics Inc is "LSTA."
What Stock Exchange Does Lisata Therapeutics Inc Trade On?
Lisata Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Lisata Therapeutics Inc a Good Stock to Buy?
Determining whether Lisata Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:LSTA share price (ISIN: US1280583022) to enhance your trading decisions with our free investment tools and resources.
What Is the Lisata Therapeutics Inc Share Price Today?
The Lisata Therapeutics share price today is 1.0900.
What Is the Stock Symbol for Lisata Therapeutics Inc
The stock symbol (or 'ticker') for Lisata Therapeutics Inc is "LSTA."
What Stock Exchange Does Lisata Therapeutics Inc Trade On?
Lisata Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Lisata Therapeutics Inc a Good Stock to Buy?
Determining whether Lisata Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0111
1.2300
52 wk Range
1.0111
5.0700
Unusual Post-Market activity
1/4
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.01111.2300
52 wk Range
1.01115.0700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LSTA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
0.0000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Form 8K Lisata Therapeutics Inc For: 9 June- Investing.com
Form DEF 14A Lisata Therapeutics Inc For: 24 April- Investing.com
- Neostem Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Lisata Therapeutics Inc For: 9 June
- Investing.com
Form 8K Lisata Therapeutics Inc For: 1 June- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.0000
Lisata Therapeutics Inc Earnings Call Summary for Q3/2025
- Lisata Therapeutics reported Q3 2025 EPS of -$0.49, beating analyst expectations of -$0.59, but stock fell 7.26% in aftermarket trading to $2.17.
- Operating expenses decreased 17.3% year-over-year to $4.4 million, with R&D expenses down 22.9% and net losses reduced to $4.2 million from $4.9 million.
- Despite positive earnings surprise of 16.95%, investor concerns persist about ongoing net losses and the company's ability to secure funding for future trials.
- Management anticipates upcoming phase 3 trials for sirtepotide and is focused on securing pharmaceutical partnerships to fund clinical programs.
- CEO Dr. David Mazzo highlighted positive results across various studies, while CMO Dr. Kristen Buck emphasized sirtepotide's ability to modify tumor microenvironments.
Last Updated: 06/11/2025, 22:50
Read Full TranscriptEarnings
Latest Release
29/05/2026
EPS / Forecast
-0.50 / --
Revenue / Forecast
-- / --
Compare LSTA to Peers and Sector
Metrics to compare | LSTA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLSTAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −1.9x | −0.3x | |
PEG Ratio | −0.03 | −0.05 | 0.00 | |
Price/Book | 0.9x | 1.4x | 2.6x | |
Price / LTM Sales | 58.4x | 10.1x | 2.9x | |
Upside (Analyst Target) | 244.8% | 149.4% | 56.7% | |
Fair Value Upside | Unlock | 21.2% | 10.2% | Unlock |
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. As of July 21, 2026, Lisata Therapeutics, Inc. operates as a subsidiary of Kuva Labs, Inc.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Lisata Therapeutics (NASDAQ: LSTA) Share Price Today?
The Lisata Therapeutics stock price today is 1.0900 USD.
What Stock Exchange Does Lisata Therapeutics (LSTA) Trade On?
Lisata Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Lisata Therapeutics?
The stock symbol (also called a 'ticker') for Lisata Therapeutics is "LSTA."
What Is the Current Lisata Therapeutics Market Capitalisation?
As of today, Lisata Therapeutics (NASDAQ: LSTA) market cap is 9.9300M USD.
What Is Lisata Therapeutics's (LSTA) Earnings Per Share (TTM)?
The Lisata Therapeutics EPS is currently -1.8606 (Trailing Twelve Months).
When Is the Next Lisata Therapeutics Earnings Date?
Lisata Therapeutics's next earnings report will be released on 17/08/2026.
Is LSTA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Lisata Therapeutics moving averages and other technical indicators, the daily buy/sell signal for LSTA stock is Strong Sell.
How Many Times Has Lisata Therapeutics Stock Split?
Lisata Therapeutics has split 6 times. (See the LSTA stock split history page for full effective split date and price information.)
How Many Employees Does Lisata Therapeutics Have?
Lisata Therapeutics has 21 employees, based on their latest Companies House report.
What is the current trading status of Lisata Therapeutics (NASDAQ: LSTA)?
As of 30/07/2026, Lisata Therapeutics (LSTA) is trading at a share price of 1.0900 USD, with a previous close of 1.0900 USD. The stock has fluctuated within a day range of 1.0111 USD to 1.2300 USD, while its 52-week range spans from 1.0111 USD to 5.0700 USD.
What Is the LSTA Premarket Price?
LSTA's last pre-market stock price is 1.1400 USD. The pre-market share volume is 3,350.0000, and the stock has decreased by -0.0200, or -1.7200%.
What Is the LSTA After Hours Price?
LSTA's last after hours stock price is 1.0293 USD, the stock has decreased by -0.0607, or -5.5700%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.